Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma
Clinical trial NCT01681212 · COMPLETED
Trial details
- NCT number
- NCT01681212
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-05-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.